Laboratoires Majorelle

Laboratoires Majorelle is a French specialty pharma company focused on prescription and OTC products in women's health and urology that offer health solutions for men and women in France. The company's portfolio of products commands a strong position in the French market with its highly respected brand image and affordable pricing.

Since its founding in 2012, Majorelle has developed the most relevant and dynamic women’s health product range in the French market, meeting unmet medical needs, making new treatments available to patients, and offering significant public health outcomes. The company has been successful in the market with the Opti® brand range of oral contraceptive pills on a continuous 28 day regimen and its products are currently used by approximately 1.8 million women. Majorelle has also built a successful urology franchise around Keat, the first wire-free medical device for urinary incontinence at home and Vitaros, the first and only topical drug for erectile dysfunction. EW will help further extend Majorelle’s product portfolio and commercial infrastructure in France and support the company’s ambition to grow into a pan-European specialty pharma company.

Transaction Summary

  • In April 2021, EW acquired a majority stake in Laboratoires Majorelle to support its growth and European expansion